Cooley LLP

During the next installment of Cooley Talks Life Sciences on October 27, Charity Williams, Chad Shear and Mika Reiner Mayer + TPG Life Sciences Innovation’s Peter Bojo will discuss: ➡️ Building an IP portfolio that supports fundraising and valuation ➡️ Key considerations when entering strategic partnerships and licensing arrangements ➡️ Preparing for and navigating patent litigation, freedom-to-operate challenges and competitive IP disputes ➡️ IP diligence considerations in M&A and other exit transactions ➡️ Practical strategies for maximizing long-term enterprise value Register now: https://bit.ly/4ihj0IE

An exciting update: Cooley has received two additional shortlistings for the 2026 Financial Times Innovative Lawyers North America Awards: ⭐ Most Innovative Law Firm in North America 2026 ⭐ Law Firm – Digital Innovation That brings our recognition to seven categories overall. Congratulations again to the teams whose work continues to push innovation forward across the firm: https://bit.ly/47uUFsO #FTInnovativeLawyers #RSGI

Cooley advised Goal Solutions, a leading provider of loan servicing, asset management, SPV administration and analytics solutions, on its significant strategic minority equity investment from the private equity investment arm of Brown Brothers Harriman, a global financial services firm. Congratulations to Goal Solutions and to the Cooley team led by Bram Couvreur, David Silverman, Rachel Shapiro and Todd Gluth, with support from Ryan Montgomery, Adam Longenbach, Tom Connors, Matthew Scarano, Tristan Prentice, Sri Ravipati and Alexander Ellebracht. 👉 Read more: https://bit.ly/4jyy7P9

We’re proud to join Viaka as Champion Host of MENA Rising NYC 2026, bringing together founders, investors and business leaders from across the Middle East and North Africa (MENA) ecosystem and beyond. Cooley partners Tamim Bazzi and Evan Leitner joined panels exploring what it takes to build, scale and invest across markets. Some key insights from the discussions: 💡 Scaling across borders requires more than replicating what worked at home. New markets can challenge assumptions about customers, operations and go-to-market strategy. 💡 As companies stay private longer, the line between private valuation and public market judgment is shifting. Growth, risk and liquidity can look very different depending on who is evaluating them. Thank you to MENA Rising for bringing the community together in New York.

Congratulations to Cooley partner Addison Pierce on being named to Crain's Chicago Business’ 2026 40 Under 40 list, recognizing rising leaders across the region. A partner in Cooley’s debt finance group, Addison advises clients on complex corporate debt transactions, including Uber’s $14 billion bridge financing tied to its acquisition of Delivery Hero. Read his full profile: https://bit.ly/4i1Ke4A

Reverse mergers are gaining traction as biotech companies look for alternative paths to the public markets. In a new Financial Times article, Cooley partner Rita Sobral discusses why more biotech companies are pursuing reverse mergers – including greater deal certainty, the ability to lock in valuation up-front and less reliance on an open IPO window. 💡 Read more.

A Cooley team – led by Yiming Liu, Michael Yu and Tonny YU – advised Akeso Biopharma (Hong Kong Stock Exchange: 9926.HK), a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world's first or best-in-class innovative biological medicines, on its HK$1.94 billion placing of new shares. Congratulations, all. Read more: https://bit.ly/3W03Hvj

A Cooley team secured a significant damages award for Inovio Pharmaceuticals, obtaining a total judgment of $80+ million, plus post-judgment interest, in a commercial litigation matter against VGXI/GeneOne in the Court of Common Pleas of Montgomery County, Pennsylvania. The Cooley team representing Inovio Pharmaceuticals was led by Mike Klisch and included Joshua Siegel, Dee Bansal, Natalie Pike, Marjory Marquardt, Rebecca Ferrari, Deepika Singh, Courtney Fisher, Hilarie Laing and Erin Combs. ➡️ Read more: https://bit.ly/4z4fEPj

October 29, 10:00 am PT: Join us for the “Connected Intelligence for In-House Legal” webinar. We’re collaborating with OpenAI for Business’s Stacey Wang and Craig Bruney and LECG (LegalEng Consulting Group)’s Mary O'Carroll to explore how AI can help in-house legal teams work with more connected context and build practical, repeatable workflows. For companies considering an IPO – whether in the near term or further down the road – Cooley partner Richard Segal will share how we’re putting those ideas into practice with GO Public, our AI-enabled IPO offering. GO Public brings AI into IPO preparation and execution to accelerate intensive drafting, support faster iteration as the deal evolves and make the process more efficient – while keeping Cooley lawyers’ judgment, experience and market insight at the center. It’s a chance to see what practical AI adoption can look like for an in-house legal team today – and how it can transform one of the most consequential moments in a company’s journey. Register today: https://bit.ly/4zNkpge

The question isn’t whether AI will transform legal work. It’s how we help shape what comes next. In a new Business Insider profile by Melia Robinson, Cooley partner and CEO Rachel Proffitt shares how we’re using AI to rethink the way we deliver value to clients and prepare the next generation of lawyers for the future. It’s part of a broader focus at Cooley on pairing technical innovation with the judgment, creativity and deep client understanding at the heart of great lawyering. Read Rachel’s perspective on the future of the legal profession: https://bit.ly/4BiGLHK